Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
16.82%
operating margin TTM
19.89%
revenue TTM
661.85 Million
revenue per share TTM
3.45$
valuation ratios | |
|---|---|
| pe ratio | 22.43 |
| peg ratio | -1.06 |
| price to book ratio | 1.93 |
| price to sales ratio | 3.77 |
| enterprise value multiple | 15.97 |
| price fair value | 1.93 |
profitability ratios | |
|---|---|
| gross profit margin | 81.32% |
| operating profit margin | 19.89% |
| pretax profit margin | 21.95% |
| net profit margin | 16.82% |
| return on assets | 6.83% |
| return on equity | 8.84% |
| return on capital employed | 9.03% |
liquidity ratios | |
|---|---|
| current ratio | 4.83 |
| quick ratio | 3.10 |
| cash ratio | 1.57 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 873.02 |
| operating cycle | 966.25 |
| days of payables outstanding | 246.13 |
| cash conversion cycle | 720.12 |
| receivables turnover | 3.92 |
| payables turnover | 1.48 |
| inventory turnover | 0.42 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.09 |
| total debt to capitalization | 0.09 |
| interest coverage | 57.53 |
| cash flow to debt ratio | 1.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.33 |
| cash per share | 7.70 |
| operating cash flow per share | 4.76 |
| free cash flow operating cash flow ratio | 0.91 |
| cash flow coverage ratios | 1.53 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 11.06 |
Frequently Asked Questions
When was the last time BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported earnings?
BioMarin Pharmaceutical Inc. (BMRN) published its most recent earnings results on 28-10-2025.
What is BioMarin Pharmaceutical Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)'s trailing twelve months ROE is 8.84%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioMarin Pharmaceutical Inc. (BMRN) currently has a ROA of 6.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BMRN's net profit margin stand at?
BMRN reported a profit margin of 16.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BMRN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.83 in the most recent quarter. The quick ratio stood at 3.10, with a Debt/Eq ratio of 0.10.